ARTICLE | Company News
PDI Therapeutics Inc., GlaxoSmithKline cancer news
May 30, 2016 7:00 AM UTC
Avalon Ventures launched cancer immunotherapy company PDI Therapeutics as part of an expanded build-to-buy partnership with GlaxoSmithKline. PDI Therapeutics is developing antibodies that inhibit prot...